Application 017037

Type
NDA
Sponsor
HIKMA

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001HEPARIN SODIUMHEPARIN SODIUMINJECTABLE;INJECTION1,000 UNITS/MLYesYes
002HEPARIN SODIUMHEPARIN SODIUMINJECTABLE;INJECTION5,000 UNITS/MLYesYes
003HEPARIN SODIUMHEPARIN SODIUMINJECTABLE;INJECTION10,000 UNITS/MLYesYes
013HEPARIN SODIUMHEPARIN SODIUMINJECTABLE;INJECTION5,000 UNITS/0.5MLNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
0641-0391Heparin SodiumHeparin SodiumWest-Ward Pharmaceuticals Corp.NDACurrent
0641-0391Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0391Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0391Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0391Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0400Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0400Heparin SodiumHeparin SodiumWest-Ward Pharmaceuticals Corp.NDACurrent
0641-0400Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0400Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0400Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0410Heparin SodiumHeparin SodiumWest-Ward Pharmaceuticals Corp.NDACurrent
0641-0410Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0410Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0410Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-0410Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-2450Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-2450Heparin SodiumHeparin SodiumWest-Ward Pharmaceuticals Corp.NDACurrent
0641-2450Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-2450Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-2450Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-2460Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-2460Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-2460Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-2460Heparin SodiumHeparin SodiumWest-Ward Pharmaceuticals Corp.NDACurrent
0641-2460Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-6199Heparin SodiumHeparin sodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-6199Heparin SodiumHeparin sodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-6199Heparin SodiumHeparin sodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-6199Heparin SodiumHeparin sodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-6204Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
0641-6204Heparin SodiumHeparin SodiumHikma Pharmaceuticals USA Inc.NDACurrent
55154-5130Heparin SodiumHeparin SodiumCardinal HealthNDACurrent
55154-5130Heparin SodiumHeparin SodiumCardinal HealthNDACurrent
55154-5130Heparin SodiumHeparin SodiumCardinal HealthNDACurrent
55154-5130Heparin SodiumHeparin SodiumCardinal Health 107, LLCNDACurrent
55154-5130Heparin SodiumHeparin SodiumCardinal HealthNDACurrent
72572-250Heparin SodiumHeparin SodiumCivica, Inc.NDACurrent
72572-250Heparin SodiumHeparin SodiumCivica, Inc.NDACurrent
72572-255Heparin SodiumHeparin SodiumCivica, Inc.NDACurrent
72572-255Heparin SodiumHeparin SodiumCivica, Inc.NDACurrent

Documents

DocumentSubmission typeDate
80006SUPPL 2024-10-28
79992SUPPL 2024-10-25
62455SUPPL2020-04-06
62453SUPPL2020-04-06
59471SUPPL2019-07-26
48358SUPPL2017-05-12
48334SUPPL2017-05-10
10954SUPPL2012-01-26
13077SUPPL2011-12-29
10953SUPPL2011-03-04
13076SUPPL2011-02-28
13075SUPPL2009-11-09
10952SUPPL2009-10-16
534SUPPL2009-02-19
533SUPPL2008-01-09
33220SUPPL2007-12-21
13074SUPPL2006-10-13
10951SUPPL2006-10-05
33219SUPPL2005-09-07
33218SUPPL2005-09-07
13073SUPPL2005-09-07
13072SUPPL2005-09-07
10950SUPPL2005-09-07
532SUPPL2005-09-07